
USTEKID trial
@ustekid_trial
The USTEKID trial is studying whether Ustekinumab can help extend the honeymoon period in adolescents (12-18y old) with newly diagnosed Type 1 Diabetes
ID: 970245393622630400
https://www.type1diabetesresearch.org.uk/current-trials/ustekid/ 04-03-2018 10:31:42
217 Tweet
135 Takipçi
132 Takip Edilen

Prof Gregory now explaining the USTEKID trial which is seeking to extend the "honeymoon period" after diagnosis and several other objectives #CYPDNWales


Involved in critical care/emergency/trauma research involving adults lacking capacity to consent? We are developing interventions to enhance decisions made by consultees/legal reps & would love your input into our survey to identify the core outcomes delphimanager.liv.ac.uk/CONSIDER/Delphi

Decided to set a target for this month to get to our half way mark for recruitment. We have 34 patients randomised for in USTEKID trial and we need 36 by the end of March. Keep posted for our progress Swansea Trials Unit T1DUK Research Consortium @DRUCymru CYP Wales Diabetes Network Manager Diabetes UK Research

Got number 35 randomised today thanks to UCLH Paediatric Research led by Dr Rakesh Amin and Lucy Wellings. Only 1 more needed for the half way mark. T1DUK Research Consortium Swansea Trials Unit





Check out the article on how the USTEKID trial kept treating its participants during the lockdown early this year as well as other amazing research being done by the South West Research Hub T1DUK Research Consortium Swansea Trials Unit


We're back on twitter with news that we've nearly reached our recruitment target. Only 2 more patients to be screened and we're there!!!! Watch this space! T1DUK Research Consortium Swansea Trials Unit National Institute for Health and Care Research


So proud to announce that the USTEKID trial has completed recruitment thanks to our amazing sites. Thank you all for your hard work and dedication to make this a success. 🥳 Swansea Trials Unit T1D National Institute for Health and Care Research



Getting close to reaching the end of the trial data collection period now! Last participant visit is due Sept 2022, then all hands on deck to start analysis! Swansea Trials Unit T1DUK Research Consortium Diabetes Research Group Swansea